文献速递特殊人群用药

半生理富集群体药动学模型预测妊娠对细胞毒性药物药动学的影响

Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs.
PubMed 文献 · Clin Pharmacokinet · 2023-06-23

本研究将妊娠期血浆蛋白、肾功能、肝功能、血浆容量、细胞外水和总体水的变化整合到多西他赛、紫杉醇、表柔比星和多柔比星的现有群体药动学模型中,预测妊娠患者的药动学特征并与观察数据比较。模型能较好描述观察数据,但多西他赛、紫杉醇和多柔比星低浓度存在过预测,可能因缺乏代谢酶妊娠变化数据。对紫杉醇、表柔比星和多柔比星,半生理富集模型预测优于未调整妊娠变化的模型。

要点

  • 将妊娠期生理变化整合入现有群体药动学模型可预测妊娠患者血药浓度。
  • 多西他赛、紫杉醇和多柔比星低浓度存在过预测,可能与代谢酶数据缺乏有关。
  • 紫杉醇、表柔比星和多柔比星用半生理富集模型预测更优。

核心结论

  • 将妊娠期生理变化纳入现有群体药动学模型可充分预测妊娠患者药物血浆浓度,可能为剂量调整提供依据。

研究设计与样本

  • 将妊娠期血浆蛋白水平、肾功能、肝功能、血浆容量、细胞外水和总体水的变化整合到多西他赛、紫杉醇、表柔比星和多柔比星的现有经验性群体药动学模型中,预测妊娠患者药动学特征并与观察数据比较。

主要发现

  • 模型能较好描述观察到的药动学特征。
  • 多西他赛、紫杉醇和多柔比星低浓度存在过预测,可能因缺乏代谢酶妊娠变化数据。
  • 对紫杉醇、表柔比星和多柔比星,半生理富集模型预测妊娠患者药动学优于未调整妊娠变化的模型。

临床怎么用

  • 可利用整合妊娠期生理变化的群体药动学模型预测紫杉醇、表柔比星和多柔比星等细胞毒性药物在妊娠患者中的血浆浓度,辅助剂量调整决策。

局限性

  • 多西他赛、紫杉醇和多柔比星低浓度过预测,可能因缺乏代谢酶妊娠变化数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: As a result of changes in physiology during pregnancy, the pharmacokinetics (PK) of drugs can be altered. It is unclear whether under- or overexposure occurs in pregnant cancer patients and thus also whether adjustments in dosing regimens are required. Given the severity of the malignant disease and the potentially high impact on both the mother and child, there is a high unmet medical need for adequate and tolerable treatment of this patient population. We aimed to develop and evaluate a semi-physiological enriched model that incorporates physiological changes during pregnancy into available population PK models developed from non-pregnant patient data. METHODS: Gestational changes in plasma protein levels, renal function, hepatic function, plasma volume, extracellular water and total body water were implemented in existing empirical PK models for docetaxel, paclitaxel, epirubicin and doxorubicin. These models were used to predict PK profiles for pregnant patients, which were compared with observed data obtained from pregnant patients. RESULTS: The observed PK profiles were well described by the model. For docetaxel, paclitaxel and doxorubicin, an overprediction of the lower concentrations was observed, most likely as a result of a lack of data on the gestational changes in metabolizing enzymes. For paclitaxel, epirubicin and doxorubicin, the semi-physiological enriched model performed better in predicting PK in pregnant patients compared with a model that was not adjusted for pregnancy-induced changes. CONCLUSION: By incorporating gestational changes into existing population pharmacokinetic models, it is possible to adequately predict plasma concentrations of drugs in pregnant patients which may inform dose adjustments in this population.

来源:Clin Pharmacokinet,查看原文。版权归原作者所有。

引用

  1. Janssen JM, Damoiseaux D, van Hasselt JGC, et al. Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs. Clin Pharmacokinet. 2023. PMID: 37351792. doi:10.1007/s40262-023-01263-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。